Anxiety Medication Articles & Analysis
7 news found
At best, most of us tolerate needles. Whether a vaccine, an IV drip, or a blood draw, we can talk ourselves through it with the knowledge that it is for the greater good and will only cause temporary discomfort. On the other side of the spectrum, there are people with such an intense fear of needles that they are considered to have a phobia, trypanophobia to be precise. Many articles have been ...
Key findings from the completed 30 mg cohort of the SHORELINE Study, other clinical data and health economics and outcomes research (HEOR), and patient survey data being presented include: In an analysis of patients in the 30 mg cohort of the SHORELINE Study with elevated anxiety (n=569) and without elevated anxiety (n=156), there was a mean reduction in the ...
Based on this data, we’re confident in the ability of CTx-2103 to provide patients with the opportunity for entire-day efficacy, safety, and convenience in a once-daily anxiety medication.” Anxiety disorders are the most common mental health concern in the U.S.1 An estimated 31 percent of U.S. adults experience an ...
Oncomfort, the Belgian inventor of and leader in Digital Sedation - a new method for relieving patients’ pain and anxiety without medication - today announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. ...
Oncomfort, the leader in Digital SedationTM for relieving patients’ pain and anxiety without medication, is pleased to announce the appointment of Karl Schweitzer as non-executive Director and Chairman of the Board. With this appointment, Oncomfort brings on board the experienced leadership to guide the organisation in its global expansion and significant ...
This certification confirms that Oncomfort manages the design, manufacturing and distribution of its Digital Sedation™ medical device and its Sedakit™, in its quality management system according to the latest regulatory requirements in the medical field. Oncomfort is developing the Sedakit™ that delivers the Digital Sedation™ therapeutic ...
Oncomfort, the Belgian inventor of Digital SedationTM - a new method for relieving patients’ pain and anxiety without medication –, and Vygon, global group specializing in single-use medical devices, today announce their commercial partnership in six European countries. ...